Seeking Alpha

EDAP TMS SA (EDAP +15.5%) gets a pop after submitting its Pre-Market Approval Application to the...

EDAP TMS SA (EDAP +15.5%) gets a pop after submitting its Pre-Market Approval Application to the FDA for Ablatherm-HIFU, a high intensity ultrasound for the treatment of low risk, localized prostate cancer. Included in EDAP's submission is positive data from its Phase 3 clinical trials and encouraging statistics from its worldwide database of treatment information and follow-up data from patients who have already undergone the therapy.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)